IRCT2015011716666N2已完成未知
The comparison of the effect of magnesium oxide and sodium valproate in migraine prophilaxis: A prospective double blind randomized clinical trial
Mazandaran University of Medical Sceinces0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15 years 至 65 years（—）
- 性别
- All
入选标准
- •migraine headache on based criteria IHS; age between 15-65 years old; migraine headache from 6 month ago; headache frequency: more than twice a month with moderate or sever intensity; not used valproate Na and MG within the past 30 days.
- •Exclusion criteria: pregnancy; breastfeeding; renal and hepatic failure; non migraine headache; smoking and opium and substance abuse.
排除标准
- 未提供
研究者
相似试验
已完成
3 期
Effect of magnesium oxide supplementation on the gene expression associated with insulin, lipid and inflammatory metabolism in diabetic hemodialysis patientsHemodialysis.End stage renal diseaseN18.6IRCT20190912044757N1Islamic Azad University60
已完成
不适用
Evaluation of the effect of magnesium oxide on the pharmacokinetics of levodopa/carbidopahealthy male and femaleJPRN-UMIN000025222Clinical Pharmacokinetics, Graduate School of Pharmaceutical Sciences, Kyushu University10
招募中
2 期
Magnesium Oxide and Vitamin C in MigraineMigraine with auraMigraine without auraIRCT20201221049787N1Shahre-kord University of Medical Sciences82
招募中
2 期
Investigating the effect of magnesium supplementation on cardiorenal syndromeIRCT20230723058900N1Rasht University of Medical Sciences30
已完成
2 期
The effect of Magnesium Oxide on Improvement of Carotid intima media Thickness in hemodialysis patientsEnd Stage Renal Disease.End stage renal diseaseIRCT138808202370N4Isfahan University of Medical Sciences54